PeerView Cardiology CME/CNE/CPE Audio Podcast
Summary: PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
- Visit Website
- RSS
- Artist: PVI, PeerView Institute for Medical Education
- Copyright: 2006
Podcasts:
This program is designed to help minimize cardiovascular risk in patients with dyslipidemia. The three expert panelists discuss the value of aggressive goals for LDL-C and blood pressure, managing patients with comorbidities, and strategies for helping patients reach and stay at treatment goals.
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.
CME/CE Information - Understanding Metabolic Dysfunction in HIV
In this CME activity, an expert in the management of hypertension and congestive heart failure discusses recent data on the vasodilatory beta-blockers in the treatment of both conditions. The differences between conventional and vasodilatory beta-blockers are also highlighted.
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts in the management of acute coronary syndrome (ACS) describe the rationale and updated guidelines supporting the long-term use of dual antithrombotic therapy in patients who have undergone percutaneous coronary intervention (PCI) with stent placement. In addition, limitations regarding the pharmacokinetics of clopidogrel in this context lay the foundation for the discussion of novel antithrombotic agents in development.
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.
